Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Néphrotoxicité")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 501

  • Page / 21
Export

Selection :

  • and

Melamine Toxicity and the KidneyHAU, Anthony Kai-Ching; TZE HOI KWAN; LI, Philip Kam-Tao et al.Journal of the American Society of Nephrology. 2009, Vol 20, Num 2, pp 245-250, issn 1046-6673, 6 p.Article

Renal toxicity of therapeutic drugsJOHN, R; HERZENBERG, A. M.Journal of clinical pathology. 2009, Vol 62, Num 6, pp 505-515, issn 0021-9746, 11 p.Article

Gadolinium-induced nephrotoxicityBUHAESCU, I; IZZEDINE, H.International journal of clinical practice (Esher). 2008, Vol 62, Num 7, pp 1113-1118, issn 1368-5031, 6 p.Article

NéphrotoxicitéANGLICHEAU, D.Le Courrier de la transplantation. 2008, Vol 8, Num 1, issn 1628-8319, [26 p.]Serial Issue

Kidney toxicity of ingested uranium from drinking waterKURTTIO, Päivi; HARMOINEN, Aimo; SAHA, Heikki et al.American journal of kidney diseases. 2006, Vol 47, Num 6, pp 972-982, issn 0272-6386, 11 p.Article

Les biomarqueurs d'atteinte rénale = Kidney injury biomarkersGUEGUEN, Yann; ROUAS, Caroline; LEBLOND, François A et al.Néphrologie & thérapeutique. 2012, Vol 8, Num 3, pp 146-155, issn 1769-7255, 10 p.Article

Toxicité rénale des médicaments = Drugs renal toxicityKARIE, Svetlana; LAUNAY-VACHER, Vincent; DERAY, Gilbert et al.Néphrologie & thérapeutique. 2010, Vol 6, Num 1, pp 58-74, issn 1769-7255, 17 p.Article

Néphrotoxicité des médicaments : veille bibliographique janvier 2003-décembre 2005 = Drud-induced nephrotoxicity : bibliography from January 2003 to December 2005KARIE, Svetlana; LAUNAY-VACHER, Vincent; IZZEDINE, Hassane et al.Néphrologie & thérapeutique. 2006, Vol 2, Num 6, pp 368-378, issn 1769-7255, 11 p.Article

L'essentiel de l'année 2006 en pharmacologie clinique cardiovasculaire = The best of clinical pharmacology in 2006AMBROSI, P; DRICI, M. D; HERPIN, D et al.Archives des maladies du coeur et des vaisseaux. 2007, Vol 100, pp 99-102, issn 0003-9683, 4 p., NS1Conference Paper

Néphrotoxicité des médicaments : veille bibliographique janvier 2003-décembre 2004 = Drug-induced nephrotoxicity : bibliography from January 2003 to December 2004KARIE, Svetlana; LAUNAY-VACHER, Vincent; IZZEDINE, Hassane et al.Néphrologie & thérapeutique. 2005, Vol 1, Num 5, pp 285-295, issn 1769-7255, 11 p.Article

Les médicaments dangereux pour le rein = Dangerous drugs for the kidneyGHUYSEN, M. S.Archives de pédiatrie (Paris). 2005, Vol 12, Num 6, pp 728-730, issn 0929-693X, 3 p.Conference Paper

Néphrotoxicité des anticancéreux : La néphrotoxicité médicamenteuseBAAKRIM, A; BENLMOUDEN, A; ZAMD, M et al.Espérance médicale. 2009, Vol 16, Num 162, pp 449-454, 6 p.Article

Science to Practice: A New Insight into Nephrotoxicity after Contrast Medium AdministrationPRINCE, Martin R; HONGLEI ZHANG; NEWHOUSE, Jeffrey H et al.Radiology. 2012, Vol 265, Num 3, pp 651-653, issn 0033-8419, 3 p.Article

Cyclosporine nephrotoxicityGRINYO, J. M; CRUZADO, J. M.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 240-242, issn 0041-1345, 3 p., SUPArticle

Cyclosporine A nephrotoxicity ― the role of thromboxane A2GRACE, A. A.Prostaglandins, leukotrienes and essential fatty acids. 1988, Vol 32, Num 4, pp 157-164, issn 0952-3278Article

MEDICINES AND THE KIDNEYVERPOOTEN, G. A.Acta Clinica Belgica. 2008, Vol 63, Num 3, pp 135-141, issn 0001-5512, 7 p.Article

Cyclosporine nephrotoxicityBUSAUSCHINA, A; SCHNUELLE, P; VAN DER WOUDE, F. J et al.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 229-233, issn 0041-1345, 5 p., SUPArticle

Effects of the calcium channel blocker diltiazem on cyclosporin nephrotoxicity in renal transplant patientsFERGUSON, C. J; WILLIAMS, J. D; HILLIS, A. N et al.Clinical transplantation. 1992, Vol 6, Num 5, pp 391-398, issn 0902-0063Article

Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective InterventionsCIARIMBOLI, Giuliano; DEUSTER, Dirk; KOEPSELL, Hermann et al.The American journal of pathology. 2010, Vol 176, Num 3, pp 1169-1180, issn 0002-9440, 12 p.Article

Selectivity still has its price : personal experiences with cyclosporine over the last 10 yearsMIHATSCH, M. J.Transplantation proceedings. 1992, Vol 24, Num 4, pp 67-70, issn 0041-1345, SUP2Conference Paper

EVIDENCE THAT DIFFERENT ANTIBODIES ARE INVOLVED IN THE PRODUCTION OF IMMUNOLOGICALLY INDUCED TERATOGENESIS AND NEPHRITISLEUNG CCK; URDANETA A; JENSH RP et al.1974; J. IMMUNOL.; U.S.A.; DA. 1974; VOL. 113; NO 3; PP. 885-895; BIBL. 35REF.Article

The absence of a deleterious effect of mechanical kidney preservation in the era of cyclosporineJAFFERS, G. J; BANOWSKY, L. H.Transplantation. 1989, Vol 47, Num 4, pp 734-736, issn 0041-1337Article

Généralités sur la toxicité rénale des médicaments : La néphrotoxicité médicamenteuseZAMD, M; BENLMOUDEN, A; HAKKOU, F et al.Espérance médicale. 2009, Vol 16, Num 162, pp 432-436, 5 p.Article

Néphrotoxicité des immunosuppresseurs : La néphrotoxicité médicamenteuseHANAFI, L; BENLMOUDEN, A; ZAMD, M et al.Espérance médicale. 2009, Vol 16, Num 162, pp 455-458, 4 p.Article

Cyclosporine nephrotoxicityFELLSTRÖM, B.Transplantation proceedings. 2004, Vol 36, Num 2S, pp 220-223, issn 0041-1345, 4 p., SUPArticle

  • Page / 21